{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:22:12Z","timestamp":1790270532362,"version":"4.1.0"},"reference-count":13,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ACR Open Rheumatology"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Chimeric antigen receptor (CAR) T\u2010cell therapy, long transformative in oncology, is now rapidly emerging as a frontier in autoimmune rheumatic diseases, particularly systemic lupus erythematosus (SLE), driven by accumulating evidence of deep B\u2010cell depletion, immune \u201cresetting,\u201d and durable drug\u2010free remission in early studies, yet its translation into rheumatology demands mastery of formidable logistical, regulatory, clinical, and ethical complexities that span institutional readiness, multidisciplinary team formation, stringent regulatory compliance, sophisticated operational workflows, comprehensive patient selection and education, meticulous clinical management of both classical toxicities (CRS, ICANS, ICAHT) and autoimmune\u2010specific reactions such as LICATS, robust financial and resource planning, and long\u2010term follow\u2010up extending 15 years or more; successful implementation requires coordinated expertise among rheumatologists, hematologist\u2010oncologists, cellular therapy units, pharmacists, research coordinators, and ICU\u2010capable teams, all embedded within disciplined communication structures, harmonized SOPs, validated PROs, biorepository governance frameworks, and adherence to national and international cellular therapy standards; in parallel, investigators must anticipate bottlenecks such as apheresis access, manufacturing slot scarcity, competing trial enrollment, fluctuating SLE phenotypes, and heterogeneity\u2010driven signal variability, while sustaining patient engagement over years through education, navigation support, and transparent risk\/benefit communication; finally, collaboration with industry partners, clinical trial networks, and patient\u2010advocacy organizations is essential for overcoming operational barriers, securing financial sustainability, and ensuring ethical stewardship, so that CAR T\u2010cell clinical trials in autoimmunity can be executed safely, rigorously, and with maximal therapeutic promise for patients.<\/jats:p>","DOI":"10.1002\/acr2.70139","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:12:31Z","timestamp":1764385951000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases"],"prefix":"10.1002","volume":"7","author":[{"given":"Roberto","family":"Caricchio","sequence":"first","affiliation":[{"name":"Lupus Center, University of Massachusetts Chan Medical School  Worcester"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacie","family":"Bell","sequence":"additional","affiliation":[{"name":"Lupus Therapeutics, Lupus Research Alliance  New York New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-2802","authenticated-orcid":false,"given":"Sasha","family":"Bernatsky","sequence":"additional","affiliation":[{"name":"Department of Medicine McGill University  Montreal Quebec Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dall'Era","sequence":"additional","affiliation":[{"name":"Lupus Clinic, University of California  San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goddard","sequence":"additional","affiliation":[{"name":"New York University Langone Hospital\u2013  Brooklyn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Kalunian","sequence":"additional","affiliation":[{"name":"Lupus Center, University of California  San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4074-0516","authenticated-orcid":false,"given":"Alfred H. J.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine Washington University School of Medicine  St. Louis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Koumpouras","sequence":"additional","affiliation":[{"name":"Yale School of Medicine, Yale University  New Haven Conneticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Rubio","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-1083","authenticated-orcid":false,"given":"Amit","family":"Saxena","sequence":"additional","affiliation":[{"name":"Grossman School of Medicine, New York University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4128-0443","authenticated-orcid":false,"given":"Saira","family":"Sheikh","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Lupus Clinical Investigators Network","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-023-06243-w"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01139-z"},{"issue":"9","key":"e_1_2_4_4_1","article-title":"Safety and efficacy of CABA\u2010201, a fully human, autologous 4\u20101BB anti\u2010CD19 CAR T cell therapy in patients with immune\u2010mediated necrotizing myopathy and systemic lupus erythematosus from the RESET\u2010MyositisTM and RESET\u2010SLETM clinical trials [abstract]","volume":"76","author":"Sheikh S","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1177\/09612033251335798"},{"key":"e_1_2_4_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2308917"},{"key":"e_1_2_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2024.07.005"},{"key":"e_1_2_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00377-1"},{"key":"e_1_2_4_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028375"},{"key":"e_1_2_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(24)00240-6"},{"key":"e_1_2_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102476"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00091-8"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacig.2024.100283"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02767-w"}],"container-title":["ACR Open Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr2.70139","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:16:42Z","timestamp":1767345402000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr2.70139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":13,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1002\/acr2.70139"],"URL":"https:\/\/doi.org\/10.1002\/acr2.70139","archive":["Portico"],"relation":{},"ISSN":["2578-5745","2578-5745"],"issn-type":[{"value":"2578-5745","type":"print"},{"value":"2578-5745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"2025-07-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70139"}}